Multiple Myeloma in Relapse research hub
5 indexed studies · 3 currently recruiting
- recruitingNA
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
This study looks at adding early support care for people with multiple myeloma or aggressive lymphoma. It wants to see if this helps improve their well-being, mood, and how they feel about their care, compared to standard care alone.
Canada - active not recruitingPHASE4
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
This study helps people with certain cancers or GvHD who are already taking ibrutinib and benefiting from it. It allows them to keep getting the medication if they can't get it commercially and helps researchers learn more about its long-term use.
United States · Australia · Canada - recruitingPHASE1, PHASE2
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
This study is testing a new medicine, STP938, for adults with specific types of lymphoma (blood cancer) that have come back after previous treatments. It aims to find a safe dose and see how well it works in different kinds of B-cell and T-cell lymphomas.
United States · France · United Kingdom - active not recruitingPHASE1, PHASE2
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
This study is testing a new cell therapy called Prizlo-Cel for adults with certain types of B-cell non-Hodgkin lymphoma that has returned or is hard to treat. It aims to see if this treatment, which uses your own specially modified cells, is safe and effective.
United States · Australia · Canada - recruitingPHASE1, PHASE2
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
This study is testing a new medicine, ALETA-001, for people with certain types of B-cell lymphoma. It's for those who have already had a specific CAR T-cell treatment. The study will look at how safe and effective ALETA-001 is.
United Kingdom